Company news
Tenaya Therapeutics, Inc. news in 2024
Tenaya Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
December 16, 2024
Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024
December 15, 2024
Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
November 24, 2024
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 5, 2024
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
October 16, 2024
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
September 2, 2024
Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 7, 2024
Tenaya Therapeutics Announces Research Leadership Updates
June 26, 2024
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
June 17, 2024
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 13, 2024
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
May 1, 2024
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 17, 2024
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
March 17, 2024
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
February 25, 2024
Tenaya Therapeutics Announces Pricing of Underwritten Offering
February 7, 2024
Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
January 2, 2024
Decks in 2024
- Technical Presentation (December 2024)
Technical · 28 slides · Dec 17, 2024